10-Q Filing

BIO-TECHNE CORP CIK: 842023 Q2 2021

Filing Information

Form Type	10-Q
Accession Number	`0001437749-21-002157`
Period End Date	20201231
Filing Date	20210208
Fiscal Year	2021
Fiscal Period	Q2
XBRL Instance	tech20201231_10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 94 Income Statement 96 Cash Flow Statement 79

Balance Sheet 94 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$775.00K	USD	Point-in-time
Accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$1.53M	USD	Point-in-time
Undesignated capital stock, no par (in dollars per share)	`UndesignatedCapitalStockNoParValue`	-	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$146.62M	USD	Point-in-time
Undesignated capital stock, no par (in dollars per share)	`UndesignatedCapitalStockNoParValue`	-	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$165.53M	USD	Point-in-time
Short-term available-for-sale investments	`AvailableForSaleSecuritiesCurrent`	$117.43M	USD	Point-in-time
Undesignated capital stock, shares authorized (in shares)	`UndesignatedCapitalStockSharesAuthorized`	5.00M	shares	Point-in-time
Undesignated capital stock, shares authorized (in shares)	`UndesignatedCapitalStockSharesAuthorized`	5.00M	shares	Point-in-time
Short-term available-for-sale investments	`AvailableForSaleSecuritiesCurrent`	$124.27M	USD	Point-in-time
Accounts receivable, net of $1,526 and $775 of reserves, respectively	`AccountsReceivableNetCurrent`	$122.53M	USD	Point-in-time
Accounts receivable, net of $1,526 and $775 of reserves, respectively	`AccountsReceivableNetCurrent`	$128.24M	USD	Point-in-time
Undesignated capital stock, shares issued (in shares)	`UndesignatedCapitalStockSharesIssued`	0.00	shares	Point-in-time
Undesignated capital stock, shares issued (in shares)	`UndesignatedCapitalStockSharesIssued`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$106.59M	USD	Point-in-time
Undesignated capital stock, shares outstanding (in shares)	`UndesignatedCapitalStockSharesOutstanding`	0.00	shares	Point-in-time
Undesignated capital stock, shares outstanding (in shares)	`UndesignatedCapitalStockSharesOutstanding`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$103.15M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$24.15M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$24.34M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$520.92M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$541.93M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$176.83M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	38.77M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$195.60M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	38.45M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	38.45M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	38.77M	shares	Point-in-time
Right of use asset	`OperatingLeaseRightOfUseAsset`	$68.15M	USD	Point-in-time
Right of use asset	`OperatingLeaseRightOfUseAsset`	$71.47M	USD	Point-in-time
Goodwill	`Goodwill`	$746.67M	USD	Point-in-time
Goodwill	`Goodwill`	$728.31M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$504.17M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$516.54M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$13.52M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$11.34M	USD	Point-in-time
Total assets	`Assets`	$2.03B	USD	Point-in-time
Total assets	`Assets`	$2.07B	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$23.09M	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$24.25M	USD	Point-in-time
Salaries, wages and related accruals	`EmployeeRelatedLiabilitiesCurrent`	$31.09M	USD	Point-in-time
Salaries, wages and related accruals	`EmployeeRelatedLiabilitiesCurrent`	$31.91M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$13.97M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$9.09M	USD	Point-in-time
Contract liabilities	`ContractWithCustomerLiabilityCurrent`	$13.05M	USD	Point-in-time
Contract liabilities	`ContractWithCustomerLiabilityCurrent`	$13.22M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$3.66M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$2.38M	USD	Point-in-time
Operating lease liabilities - current	`OperatingLeaseLiabilityCurrent`	$9.54M	USD	Point-in-time
Operating lease liabilities - current	`OperatingLeaseLiabilityCurrent`	$9.91M	USD	Point-in-time
Contingent consideration payable	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$5.94M	USD	Point-in-time
Contingent consideration payable	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$4.98M	USD	Point-in-time
Current portion of long-term debt obligations	`LongTermDebtCurrent`	$12.50M	USD	Point-in-time
Current portion of long-term debt obligations	`LongTermDebtCurrent`	$12.50M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$3.17M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$106.67M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$117.57M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$105.34M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$101.09M	USD	Point-in-time
Long-term debt obligations	`LongTermDebtAndCapitalLeaseObligations`	$344.24M	USD	Point-in-time
Long-term debt obligations	`LongTermDebtAndCapitalLeaseObligations`	$219.03M	USD	Point-in-time
Long-term contingent consideration payable	`BusinessCombinationContingentConsiderationLiabilityNoncurrent`	$199.00K	USD	Point-in-time
Long-term contingent consideration payable	`BusinessCombinationContingentConsiderationLiabilityNoncurrent`	$5.60M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$63.67M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$67.25M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$25.80M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$26.95M	USD	Point-in-time
Undesignated capital stock, no par; authorized 5,000,000 shares; none issued or outstanding	`UndesignatedCapitalStockValue`	-	USD	Point-in-time
Undesignated capital stock, no par; authorized 5,000,000 shares; none issued or outstanding	`UndesignatedCapitalStockValue`	-	USD	Point-in-time
Common stock, par value $.01 per share; authorized 100,000,000; issued and outstanding 38,765,300 and 38,453,046, respectively	`CommonStockValue`	$388.00K	USD	Point-in-time
Common stock, par value $.01 per share; authorized 100,000,000; issued and outstanding 38,765,300 and 38,453,046, respectively	`CommonStockValue`	$385.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$420.54M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$481.00M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.10B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.06B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-97.20M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-64.24M	USD	Point-in-time
Total Bio-Techne shareholders' equity	`StockholdersEquity`	$1.17B	USD	Point-in-time
Total Bio-Techne shareholders' equity	`StockholdersEquity`	$1.32B	USD	Point-in-time
Total Bio-Techne shareholders' equity	`StockholdersEquity`	$1.17B	USD	Point-in-time
Total Bio-Techne shareholders' equity	`StockholdersEquity`	$1.52B	USD	Point-in-time
Total Bio-Techne shareholders' equity	`StockholdersEquity`	$1.38B	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	-	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$8.94M	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.44B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.38B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.53B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$2.07B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$2.03B	USD	Point-in-time

Income Statement 96 line items

Line Item	Tag	Value	Unit	Period
Net sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$368.18M	USD	2 Qtrs
Net sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$224.25M	USD	1 Quarter
Net sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$428.45M	USD	2 Qtrs
Net sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$184.93M	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$63.53M	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$73.35M	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$128.36M	USD	2 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$139.82M	USD	2 Qtrs
Gross margin	`GrossProfit`	$150.90M	USD	1 Quarter
Gross margin	`GrossProfit`	$239.82M	USD	2 Qtrs
Gross margin	`GrossProfit`	$288.63M	USD	2 Qtrs
Gross margin	`GrossProfit`	$121.40M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$83.12M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$68.03M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$155.71M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$137.04M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$16.38M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$32.46M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$32.83M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$16.79M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$188.54M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$99.91M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$169.50M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$84.41M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$70.32M	USD	2 Qtrs
Operating income	`OperatingIncomeLoss`	$50.99M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$100.09M	USD	2 Qtrs
Operating income	`OperatingIncomeLoss`	$36.99M	USD	1 Quarter
Other (expense) income	`NonoperatingIncomeExpense`	$-4.38M	USD	2 Qtrs
Other (expense) income	`NonoperatingIncomeExpense`	$97.81M	USD	2 Qtrs
Other (expense) income	`NonoperatingIncomeExpense`	$113.33M	USD	1 Quarter
Other (expense) income	`NonoperatingIncomeExpense`	$5.37M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$168.13M	USD	2 Qtrs
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$95.71M	USD	2 Qtrs
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$56.37M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$150.33M	USD	1 Quarter
Income taxes	`IncomeTaxExpenseBenefit`	$10.22M	USD	1 Quarter
Income taxes	`IncomeTaxExpenseBenefit`	$30.70M	USD	1 Quarter
Income taxes	`IncomeTaxExpenseBenefit`	$16.17M	USD	2 Qtrs
Income taxes	`IncomeTaxExpenseBenefit`	$34.11M	USD	2 Qtrs
Net earnings, including noncontrolling interest	`ProfitLoss`	$46.14M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$119.62M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$33.40M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$134.02M	USD	2 Qtrs
Net earnings, including noncontrolling interest	`ProfitLoss`	$79.54M	USD	2 Qtrs
Net earnings attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	2 Qtrs
Net earnings attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Net earnings attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-130.00K	USD	1 Quarter
Net earnings attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-130.00K	USD	2 Qtrs
Net earnings attributable to Bio-Techne	`NetIncomeLoss`	$14.40M	USD	1 Quarter
Net earnings attributable to Bio-Techne	`NetIncomeLoss`	$46.27M	USD	1 Quarter
Net earnings attributable to Bio-Techne	`NetIncomeLoss`	$119.62M	USD	1 Quarter
Net earnings attributable to Bio-Techne	`NetIncomeLoss`	$79.67M	USD	2 Qtrs
Net earnings attributable to Bio-Techne	`NetIncomeLoss`	$134.02M	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$16.93M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$11.87M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$4.26M	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$28.84M	USD	2 Qtrs
Derivative instruments - cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent`	$904.00K	USD	2 Qtrs
Derivative instruments - cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent`	$2.06M	USD	1 Quarter
Derivative instruments - cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent`	$1.41M	USD	1 Quarter
Derivative instruments - cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent`	$4.20M	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$13.28M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$14.06M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$18.99M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$5.17M	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$33.04M	USD	2 Qtrs
Other comprehensive income attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	-	USD	2 Qtrs
Other comprehensive income attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$83.00K	USD	2 Qtrs
Other comprehensive income attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$83.00K	USD	1 Quarter
Other comprehensive income attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Other comprehensive income attributable to Bio-Techne	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$13.28M	USD	1 Quarter
Other comprehensive income attributable to Bio-Techne	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$32.96M	USD	2 Qtrs
Other comprehensive income attributable to Bio-Techne	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$18.90M	USD	1 Quarter
Other comprehensive income attributable to Bio-Techne	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$5.17M	USD	2 Qtrs
Other comprehensive income attributable to Bio-Techne	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-8.11M	USD	1 Quarter
Comprehensive income attributable to Bio-Techne	`ComprehensiveIncomeNetOfTax`	$112.63M	USD	2 Qtrs
Comprehensive income attributable to Bio-Techne	`ComprehensiveIncomeNetOfTax`	$132.90M	USD	1 Quarter
Comprehensive income attributable to Bio-Techne	`ComprehensiveIncomeNetOfTax`	$139.19M	USD	2 Qtrs
Comprehensive income attributable to Bio-Techne	`ComprehensiveIncomeNetOfTax`	$65.18M	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$2.06	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.20	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$3.13	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$3.51	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$3.02	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.15	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.98	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$3.40	USD	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	38.61M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	38.69M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	38.17M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	38.10M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	39.37M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	39.55M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	40.13M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	40.26M	shares	1 Quarter

Cash Flow Statement 79 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`ProfitLoss`	$46.14M	USD	1 Quarter
Net earnings	`ProfitLoss`	$119.62M	USD	1 Quarter
Net earnings	`ProfitLoss`	$33.40M	USD	1 Quarter
Net earnings	`ProfitLoss`	$134.02M	USD	2 Qtrs
Net earnings	`ProfitLoss`	$79.54M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$41.97M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$40.64M	USD	2 Qtrs
Costs recognized on sale of acquired inventory	`FairValueWriteUpOfAcquiredInventory`	-	USD	2 Qtrs
Costs recognized on sale of acquired inventory	`FairValueWriteUpOfAcquiredInventory`	$23.00K	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$14.80M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$216.00K	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$28.53M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$18.50M	USD	2 Qtrs
Contingent consideration payments	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-155.00K	USD	2 Qtrs
Contingent consideration payments	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-145.00K	USD	2 Qtrs
Fair value adjustment to contingent consideration payable	`FairValueAdjustmentToContingentConsiderationPayable`	$4.60M	USD	2 Qtrs
Fair value adjustment to contingent consideration payable	`FairValueAdjustmentToContingentConsiderationPayable`	$100.00K	USD	2 Qtrs
Fair value adjustment on available for sale investments	`FairValueAdjustmentOnAvailableForSaleSecurities`	$-110.86M	USD	2 Qtrs
Fair value adjustment on available for sale investments	`FairValueAdjustmentOnAvailableForSaleSecurities`	$-6.36M	USD	2 Qtrs
Leases, net	`NoncashPortionOfLeaseExpense`	$113.00K	USD	2 Qtrs
Leases, net	`NoncashPortionOfLeaseExpense`	$177.00K	USD	2 Qtrs
Other operating activity	`OtherOperatingActivitiesCashFlowStatement`	$324.00K	USD	2 Qtrs
Other operating activity	`OtherOperatingActivitiesCashFlowStatement`	$160.00K	USD	2 Qtrs
Trade accounts and other receivables, net	`IncreaseDecreaseInAccountsAndOtherReceivables`	$2.33M	USD	2 Qtrs
Trade accounts and other receivables, net	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-9.95M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$4.38M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$586.00K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$1.51M	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$1.32M	USD	2 Qtrs
Trade accounts payable, accrued expenses, contract liabilities, and other	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$8.62M	USD	2 Qtrs
Trade accounts payable, accrued expenses, contract liabilities, and other	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$7.12M	USD	2 Qtrs
Salaries, wages and related accruals	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-1.71M	USD	2 Qtrs
Salaries, wages and related accruals	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-10.19M	USD	2 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$3.98M	USD	2 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$12.39M	USD	2 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$155.28M	USD	2 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$110.96M	USD	2 Qtrs
Proceeds from sale and maturities of available-for-sale investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$43.15M	USD	2 Qtrs
Proceeds from sale and maturities of available-for-sale investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$68.40M	USD	2 Qtrs
Purchases of available-for-sale investments	`PaymentsToAcquireAvailableForSaleSecurities`	$25.10M	USD	2 Qtrs
Purchases of available-for-sale investments	`PaymentsToAcquireAvailableForSaleSecurities`	$27.18M	USD	2 Qtrs
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$25.09M	USD	2 Qtrs
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$22.38M	USD	2 Qtrs
Acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$9.77M	USD	2 Qtrs
Acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	2 Qtrs
Other investing activity	`PaymentsForProceedsFromOtherInvestingActivities`	$556.00K	USD	2 Qtrs
Other investing activity	`PaymentsForProceedsFromOtherInvestingActivities`	-	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$18.21M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-16.74M	USD	2 Qtrs
Cash dividends	`PaymentsOfDividendsCommonStock`	$24.36M	USD	2 Qtrs
Cash dividends	`PaymentsOfDividendsCommonStock`	$24.73M	USD	2 Qtrs
Proceeds from stock option exercises	`ProceedsFromStockOptionsExercised`	$32.34M	USD	2 Qtrs
Proceeds from stock option exercises	`ProceedsFromStockOptionsExercised`	$27.25M	USD	2 Qtrs
Re-purchase of common stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	2 Qtrs
Re-purchase of common stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	2 Qtrs
Proceeds from long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	2 Qtrs
Proceeds from long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	2 Qtrs
Repayments of long-term debt	`RepaymentsOfLinesOfCredit`	$122.25M	USD	2 Qtrs
Repayments of long-term debt	`RepaymentsOfLinesOfCredit`	$125.25M	USD	2 Qtrs
Other financing activity	`ProceedsFromPaymentsForOtherFinancingActivities`	$-1.93M	USD	2 Qtrs
Other financing activity	`ProceedsFromPaymentsForOtherFinancingActivities`	$-7.37M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-121.30M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-125.01M	USD	2 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$5.38M	USD	2 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.53M	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$18.90M	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$9.41M	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$165.53M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$146.62M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$110.29M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$100.89M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$165.53M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$146.62M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$110.29M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$100.89M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaid`	$7.04M	USD	2 Qtrs
Cash paid for income taxes	`IncomeTaxesPaid`	$11.01M	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	$9.87M	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	$7.78M	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.